Drugs / UI15AML055MT
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02166398 | Jun → Oct 2014 | — | Korea United Pharm. Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UI15AML055MT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02166398 ↗ |
| Route | Oral | “UI15AML055MT tab given by oral administration” NCT02166398 ↗ |